TAA
KANG

TB Alternative Assets’s iKang Healthcare Group, Inc. KANG Stock Holding History

TB Alternative Assets’s Portfolio KANG Stock Details KANG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-30,649
Closed -$626K – 14
2015
Q4 		$626K Buy
+30,649
New +$529K 0.61% 15

Other funds holding KANG

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
ASI
All-Stars Investment Hong Kong $206M AUM 31.57% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

TB Alternative Assets's KANG Position: Q1 2016 in Review

TB Alternative Assets sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2016, closing a stake of 30,649 shares — an estimated $626K sold.

TB Alternative Assets first reported a position in KANG in Q4 2015 and held it in 1 quarter. The position peaked at $626K in Q4 2015. 73 funds tracked by Wall St. Rank hold KANG as of Q1 2016.

  • TB Alternative Assets reported no remaining iKang Healthcare Group, Inc. position as of Q1 2016 after selling out during the quarter.
  • TB Alternative Assets sold 30,649 iKang Healthcare Group, Inc. shares in Q1 2016, an estimated $626K.
  • TB Alternative Assets first reported a position in iKang Healthcare Group, Inc. in Q4 2015 and held it in 1 quarter.
  • TB Alternative Assets's iKang Healthcare Group, Inc. position peaked at $626K in Q4 2015.
  • 73 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2016.

Based on TB Alternative Assets's 13F filing for Q1 2016, filed 19 Apr 2016.